Henry S. Friedman, MD, Upstate Medical University, Syracuse, NY 1977
Affiliations: | Pathology | Duke University, Durham, NC |
Area:
Biology and therapy of adult and childhood central nervous system malignancies, particularly high-grade medulloblastoma, glioma, and ependymoma.Website:
http://www.cancer.duke.edu/btc/modules/facultystaff1/index.php?id=3Google:
"Henry Friedman"Bio:
http://www.cancer.duke.edu/btc/docs/files/file/CV%209_9_10.pdf
http://www.dukehealth.org/physicians/henry_s_friedman
Mean distance: 106866
Cross-listing: Neuropathology Tree
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tan AC, Ashley DM, López GY, et al. (2020) Management of glioblastoma: State of the art and future directions. Ca: a Cancer Journal For Clinicians |
| Patel MP, Kirkpatrick JP, Johnson MO, et al. (2020) Patterns of relapse after successful completion of initial therapy in primary central nervous system lymphoma: a case series. Journal of Neuro-Oncology |
| Desjardins A, Randazzo D, Chandramohan V, et al. (2020) Phase I trial of D2C7 immunotoxin (D2C7-IT) administered intratumorally via convection-enhanced delivery (CED) for recurrent malignant glioma (MG). Journal of Clinical Oncology. 38: 2566-2566 |
| Johnson MO, Kirkpatrick JP, Patel MP, et al. (2019) The role of chemotherapy in the treatment of central neurocytoma. Cns Oncology. CNS41 |
| Kim JY, Jackman JG, Woodring S, et al. (2019) Second primary cancers in long-term survivors of glioblastoma. Neuro-Oncology Practice. 6: 386-391 |
| Patel MP, Woodring S, Randazzo DM, et al. (2019) Randomized open-label phase II trial of 5-day aprepitant plus ondansetron compared to ondansetron alone in the prevention of chemotherapy-induced nausea-vomiting (CINV) in glioma patients receiving adjuvant temozolomide. Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer |
| Lipp ES, Healy P, Austin A, et al. (2019) MGMT: Immunohistochemical Detection in High-Grade Astrocytomas. Journal of Neuropathology and Experimental Neurology. 78: 57-64 |
| Desjardins A, Gromeier M, Herndon JE, et al. (2019) Oncolytic polio/rhinovirus recombinant (PVSRIPO) against WHO grade IV malignant glioma (MG): Experience with retreatment of survivors from the phase I trial. Journal of Clinical Oncology. 37: 2060-2060 |
| Randazzo D, Jackman J, Herndon J, et al. (2019) Qolp-29. Mindfulness Meditation Practice In Malignant Glioma Patients Throughout Concomitant Radiation And Temozolomide: A Feasibility Study Neuro-Oncology. 21 |
| Barbour A, Healy P, Lipp E, et al. (2019) Hout-21. Characteristics Of Short-Term Survival In Patients With Glioblastoma: A Retrospective Analysis Neuro-Oncology. 21 |